title: Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
abstract: As part of a large medicinal chemistry program, we wish to develop novel selective estrogen receptor modulators (SERMs) as potential breast cancer treatments using a combination of experimental and computational approaches. However, one of the remaining difficulties nowadays is to fully integrate computational (i.e., virtual, theoretical) and medicinal (i.e., experimental, intuitive) chemistry to take advantage of the full potential of both. For this purpose, we have developed a Web-based platform, Forecaster, and a number of programs (e.g., Prepare, React, Select) with the aim of combining computational chemistry and medicinal chemistry expertise to facilitate drug discovery and development and more specifically to integrate synthesis into computer-aided drug design. In our quest for potent SERMs, this platform was used to build virtual combinatorial libraries, filter and extract a highly diverse library from the NCI database, and dock them to the estrogen receptor (ER), with all of these steps being fully automated by computational chemists for use by medicinal chemists. As a result, virtual screening of a diverse library seeded with active compounds followed by a search for analogs yielded an enrichment factor of 129, with 98% of the seeded active compounds recovered, while the screening of a designed virtual combinatorial library including known actives yielded an area under the receiver operating characteristic (AU-ROC) of 0.78. The lead optimization proved less successful, further demonstrating the challenge to simulate structure activity relationship studies.
authors: Department of Chemistry, McGill University, 801 Sherbrooke St W, Montreal, QC, Canada H3A 2K6.
authors: Eric
authors: E
authors: Therrien
authors: Pablo
authors: P
authors: Englebienne
authors: Andrew G
authors: AG
authors: Arrowsmith
authors: Rodrigo
authors: R
authors: Mendoza-Sanchez
authors: Christopher R
authors: CR
authors: Corbeil
authors: Nathanael
authors: N
authors: Weill
authors: Valérie
authors: V
authors: Campagna-Slater
authors: Nicolas
authors: N
authors: Moitessier
mesh_terms: D000465:Algorithms; D001943:Breast Neoplasms / Q000188:drug therapy; D002625:Chemistry, Organic; D002626:Chemistry, Pharmaceutical; D020650:Combinatorial Chemistry Techniques; D017076:Computer-Aided Design; D018360:Crystallography, X-Ray; D015195:Drug Design; D055808:Drug Discovery / Q000379:methods*; D004958:Estradiol / Q000737:chemistry; D005260:Female; D006801:Humans; D008958:Models, Molecular; D012372:ROC Curve; D011960:Receptors, Estrogen / Q000819:agonists / Q000037:antagonists & inhibitors / Q000737:chemistry; D020845:Selective Estrogen Receptor Modulators / Q000737:chemistry* / Q000494:pharmacology; D012984:Software; D013329:Structure-Activity Relationship
chemical_list: D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D004958:Estradiol